Metraipolis › archive › dc_356ae8fc6117

No differences in therapeutic efficacy while sparing healthy tissue for orthotopic glioblastoma patient-derived xenografts in context of proton FLASH — Europe PMC PMID:41049393

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41049393
DOI
10.1016/j.ctro.2025.101050
License (as archived)
solo-consultazione
Archived
2026-11-09T21:10:35.547Z
SHA-256 of the archived text
73227eabf547bc20f448b29e02e73f9ca166ad4f872950f3cfa0e641bccc55d1
Stable URL of this page
https://metraipolis.com/documento/dc_356ae8fc6117

How to cite

No differences in therapeutic efficacy while sparing healthy tissue for orthotopic glioblastoma patient-derived xenografts in context of proton FLASH — Europe PMC PMID:41049393 — Europe PMC (en), https://europepmc.org/article/MED/41049393 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_356ae8fc6117 (Metraipolis archive dc_356ae8fc6117, sha256 73227eabf547bc20f448b29e02e73f9ca166ad4f872950f3cfa0e641bccc55d1)
BibTeX
@misc{dc356ae8fc6117,
  title = {No differences in therapeutic efficacy while sparing healthy tissue for orthotopic glioblastoma patient-derived xenografts in context of proton FLASH — Europe PMC PMID:41049393},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41049393},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_356ae8fc6117; sha256 73227eabf547bc20f448b29e02e73f9ca166ad4f872950f3cfa0e641bccc55d1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41049393. Agents can read the archived copy with the MCP tool read_document.